ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PRVA vs AVAH // REVENUE GROWTH (YOY)

Privia Health Group Inc. (NASDAQ) VS. Aveanna Healthcare Holdings Inc. (NASDAQ) • 15-METRIC TALLY: PRVA 1 — AVAH 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRVA VS. AVAH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PRVA AVAH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 33.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 10.50% 15.70% -5.20 AVAH /roic <GO>
EV/EBITDA & P/E Valuation 68.1x 15.5x +52.60 AVAH /valuation <GO>
Free Cash Flow Yield 5.82% 4.35% +1.47 PRVA /fcf-yield <GO>
Operating Margin — 10.50% — TIE /operating-margins <GO>
Net Profit Margin — 0.00% — TIE /net-margins <GO>
Revenue Growth (YoY) ACTIVE — 20.20% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 1.86 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 8/9 -2.00 AVAH /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.9 56.0 -7.13 AVAH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 114.0x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.81B $2.89B -$84.1M AVAH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PRVA REV AVAH REV PRVA GROSS % AVAH GROSS % PRVA FCF AVAH FCF
FY 2025 $0 $2.43B — 33.3% $163.4M $125.9M
FY 2024 $0 $2.02B — 31.4% $109.3M $32.6M
FY 2023 $0 $1.90B — — $80.8M $22.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRVA // BETA —
AVAH // BETA —